Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Acta Bio-Medica : Atenei Parmensis|March 8, 2021
Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resectionIngrid Garajova, Rita Balsano, Chiara Tommasi, et al.The Annals of Pharmacotherapy|April 8, 2010
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministrationSilvia Baroncelli, Paola Villani, Liliana E Weimer, et al.Seminars in Oncology|October 8, 2021
A review of immune checkpoint blockade in breast cancerBenedetta Pellegrino, Chiara Tommasi, Olga Elisabetta Cursio, et al.Scandinavian Journal of Infectious Diseases|January 21, 2010
Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravirChiara Tommasi, Francesca Ceccherini-Silberstein, Roberta D'Arrigo, et al.AIDS (London, England)|February 1, 2019
Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatmentRita Bellagamba, Maria Letizia Giancola, Chiara Tommasi, et al.Current HIV Research|July 6, 2012
Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up periodEmanuele Nicastri, Jelena Ivanovic, Fabrizio Signore, et al.Journal of the International AIDS Society|November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohortCarmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.Cancers|July 9, 2022
Integrated MRI-Immune-Genomic Features Enclose a Risk Stratification Model in Patients Affected by GlioblastomaGiulia Mazzaschi, Alessandro Olivari, Antonio Pavarani, et al.Journal of Clinical Medicine|April 13, 2024
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment StrategiesChiara Tommasi, Giulia Airò, Fabiana Pratticò, et al.Journal of Clinical Medicine|December 11, 2022
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?Chiara Tommasi, Rita Balsano, Matilde Corianò, et al.Pageof 5